RT Journal Article
SR Electronic
T1 Evidence and characteristics of human-to-human transmission of SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.03.20019141
DO 10.1101/2020.02.03.20019141
A1 Kang, Min
A1 Wu, Jie
A1 Ma, Wenjun
A1 He, Jianfeng
A1 Lu, Jing
A1 Liu, Tao
A1 Li, Baisheng
A1 Mei, Shujiang
A1 Ruan, Feng
A1 Lin, Lifeng
A1 Zou, Lirong
A1 Ke, Changwen
A1 Zhong, Haojie
A1 Zhang, Yingtao
A1 Chen, Xuguang
A1 Liu, Zhe
A1 Zhu, Qi
A1 Xiao, Jianpeng
A1 Yu, Jianxiang
A1 Hu, Jianxiong
A1 Zeng, Weilin
A1 Li, Xing
A1 Liao, Yuhuang
A1 Tang, Xiujuan
A1 Xiao, Songjian
A1 Wang, Ying
A1 Song, Yingchao
A1 Zhuang, Xue
A1 Liang, Lijun
A1 Zeng, Siqing
A1 He, Guanhao
A1 Lin, Peng
A1 Deng, Huihong
A1 Song, Tie
YR 2020
UL http://medrxiv.org/content/early/2020/02/17/2020.02.03.20019141.abstract
AB Background On December 31, 2019, an outbreak of COVID-19 in humans was reported in Wuhan, and then spread fast to other provinces, China. We analyzed data from field investigations and genetic sequencing to describe the evidence and characteristics of human-to-human transmission in Guangdong Province.Methods A confirmed COVID-19 case was defined if a suspected case was verified with positive of SARS-CoV-2 in throat swabs, nasal swabs, bronchoalveolar lavage fluid (BALF), or endotracheal aspirates by real-time reverse transcriptase polymerase chain reaction assay (RT-PCR) or genetic sequencing. Field investigations were conducted for each confirmed case. Clinical and demographic data of confirmed cases were collected from medical records. Exposure and travel history were obtained by interview.Results A total of 1,151 confirmed cases were identified as of February 10, 2020 in Guangdong Province, China. Of them, 697 (60.1%) cases were from 234 cluster infections. Two hundred and fourteen (18.6%) were secondary cases, in which 144 cases were from family cluster infections. With the epidemic continuing, although familial cluster events were dominated, community cluster events increased with a nosocomial event. The whole genomes within the same family cluster infections were identical, and presented a few unique single nucleotide variants (SNVs) compared with SARS-CoV-2 identified on December 2019 in Wuhan.Conclusions We observed evident human-to-human transmissions of SARS-CoV-2 in Guangdong, China. Although most of them were from family cluster infections, community and nosocomial infections were increasing. Our findings indicate that human-to-human transmission risks are transferring from family to community in Guangdong Province.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Key Research and Development Program of China (2018YFA0606200, 2018YFA0606202), the Science and Technology Program of Guangdong Province (2018B020207006, 2019B020208005, 2019B111103001), Guangzhou Science and technology Plan Project (201804010383).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are applied through the corresponding author.